What is the share price of Onesource Specialty Pharma Ltd (ONESOURCE) today?
The share price of ONESOURCE as on 2nd November 2026 is ₹1569.60. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Onesource Specialty Pharma Ltd (ONESOURCE) share?
The past returns of Onesource Specialty Pharma Ltd (ONESOURCE) share are- Past 1 week: 14.51%
- Past 1 month: -1.69%
- Past 3 months: -7.42%
- Past 6 months: -10.07%
- Past 1 year: -15.45%
- Past 3 years: N/A%
- Past 5 years: -8.60%
What are the peers or stocks similar to Onesource Specialty Pharma Ltd (ONESOURCE)?
The peers or stocks similar to Onesource Specialty Pharma Ltd (ONESOURCE) include:What is the market cap of Onesource Specialty Pharma Ltd (ONESOURCE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Onesource Specialty Pharma Ltd (ONESOURCE) is ₹17923.57 Cr as of 2nd November 2026.What is the 52 week high and low of Onesource Specialty Pharma Ltd (ONESOURCE) share?
The 52-week high of Onesource Specialty Pharma Ltd (ONESOURCE) is ₹1925 and the 52-week low is ₹1057.What is the PE and PB ratio of Onesource Specialty Pharma Ltd (ONESOURCE) stock?
The P/E (price-to-earnings) ratio of Onesource Specialty Pharma Ltd (ONESOURCE) is -242.83. The P/B (price-to-book) ratio is 3.07.Which sector does Onesource Specialty Pharma Ltd (ONESOURCE) belong to?
Onesource Specialty Pharma Ltd (ONESOURCE) belongs to the Health Care sector & Biotechnology sub-sector.How to buy Onesource Specialty Pharma Ltd (ONESOURCE) shares?
You can directly buy Onesource Specialty Pharma Ltd (ONESOURCE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Onesource Specialty Pharma Ltd
ONESOURCE Share Price
NSEONESOURCE Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
AvgAverage profitability - not good, not bad
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
ONESOURCE Performance & Key Metrics
ONESOURCE Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -10,996.06 | 3.07 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 45.81 | 5.76 | 0.50% |
from 4 analysts
Price Upside
Earnings Growth
Rev. Growth
ONESOURCE Company Profile
OneSource Specialty Pharma Ltd is a contract development and manufacturing organization specializing in complex biologics, biosimilars, and vaccines.
ONESOURCE Sentiment Analysis
ONESOURCE Sentiment Analysis
ONESOURCE Stock Summary · July 2026
Management struck a broadly upbeat tone, saying the quarter combined strong execution with rising commercial momentum across its platform. Revenue grew 37% year on year to INR 4,490 million and EBITDA increased 39% to INR 1,233 million, supported by the semaglutide launch, new MSA contracts and customer wins. A major focus was the acceleration of semaglutide commercialization, with all three market approvals now in place, partner launches underway in Canada and India, and more than 40% of the generic pens market in India already being manufactured at the company’s site by late June. Management also emphasized that capacity expansion is removing prior bottlenecks: the second cartridge line is on track this quarter, should double sterile production days, and is expected to support resumed supply to Dr. Reddy’s and new customer onboarding later in the year. Alongside this, the company described growing opportunity in softgels, injectables and biologics, while noting some near-term disruption from freight and shipping pressures. Management reiterated its FY28 target of $400 million of organic revenue and 40% EBITDA margins, saying it has sufficient visibility to support that outlook.
ONESOURCE Stock Growth Drivers
ONESOURCE Stock Growth Drivers
10Strong Revenue and EBITDA Growth
The company delivered a strong quarter, with revenue rising 37% year on year to INR
Semaglutide Commercialization Gains
Commercialization of semaglutide is accelerating across key markets, with meaningful traction already visible in Canada
ONESOURCE Stock Challenges
ONESOURCE Stock Challenges
4Capacity Constraints and Delayed Revenue Capture
The company is still operating under meaningful capacity constraints, with prior demand exceeding available sterile
Limited Near-Term Impact From Oncology Soft-Gel Launch
The first oncology soft-gel NDA is an important strategic milestone, but the commercial upside is
ONESOURCE Forecast
ONESOURCE Forecasts
Price
Revenue
Earnings
ONESOURCE Share Price Forecast
ONESOURCE Share Price Forecast
All values in ₹
All values in ₹
ONESOURCE Company Revenue Forecast
ONESOURCE Company Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
ONESOURCE Stock EPS (Earnings Per Share) Forecast
ONESOURCE Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
ONESOURCE
ONESOURCE
Income
Balance Sheet
Cash Flow
ONESOURCE Income Statement
ONESOURCE Income Statement
| Quarter | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | sep 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 296.28 | 338.45 | 399.28 | 428.84 | 332.54 | 378.80 | 294.97 | 430.34 | 452.83 | 517.20 | ||||||||||
| Operating & Other expenses | 232.51 | 262.58 | 351.20 | 244.13 | 241.66 | 269.27 | 280.11 | 336.30 | 329.98 | 354.72 | ||||||||||
| EBITDA | 63.77 | 75.87 | 48.08 | 184.71 | 90.88 | 109.53 | 14.86 | 94.04 | 122.85 | 162.48 | ||||||||||
| Depreciation/Amortization | 68.35 | 68.28 | 68.77 | 68.49 | 67.80 | 69.83 | 69.64 | 71.83 | 71.75 | 75.05 | ||||||||||
| PBIT | -4.58 | 7.59 | -20.69 | 116.22 | 23.08 | 39.70 | -54.78 | 22.21 | 51.10 | 87.43 | ||||||||||
| Interest & Other Items | 42.05 | 45.05 | 45.82 | 33.41 | 27.48 | 33.96 | 38.23 | 22.51 | 30.81 | 34.56 | ||||||||||
| PBT | -46.63 | -37.46 | -66.51 | 82.81 | -4.40 | 5.74 | -93.01 | -0.30 | 20.29 | 52.87 | ||||||||||
| Taxes & Other Items | -41.07 | 4.63 | 2.35 | -15.69 | -4.21 | -4.74 | -4.31 | -4.89 | -4.70 | -4.62 | ||||||||||
| Net Income | -5.56 | -42.09 | -68.86 | 98.50 | -0.19 | 10.48 | -88.70 | 4.59 | 24.99 | 57.49 | ||||||||||
| EPS | -0.51 | -10.13 | -6.31 | 8.61 | -0.02 | 0.92 | -7.74 | 0.40 | 2.18 | 5.01 |
ONESOURCE Company Updates
Investor Presentation
ONESOURCE Stock Peers
ONESOURCE Past Performance & Peer Comparison
ONESOURCE Past Performance & Peer Comparison
Health CareBiotechnology
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Onesource Specialty Pharma Ltd | -242.83 | 3.07 | — |
| Biocon Limited | 148.41 | 1.56 | 0.14% |
| Anthem Biosciences Limited | 78.92 | 15.35 | 0.24% |
| Sai Life Sciences Limited | 94.85 | 13.32 | — |
ONESOURCE Stock Price Comparison
Compare ONESOURCE with any stock or ETFONESOURCE Holdings
ONESOURCE Shareholdings
ONESOURCE Promoter Holdings Trend
ONESOURCE Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
ONESOURCE Institutional Holdings Trend
ONESOURCE Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
ONESOURCE Shareholding Pattern
ONESOURCE Shareholding Pattern
ONESOURCE Shareholding History
ONESOURCE Shareholding History
Mutual Funds Invested in ONESOURCE
Mutual Funds Invested in ONESOURCE
No mutual funds holding trends are available
Top 5 Mutual Funds holding Onesource Specialty Pharma Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 3.1596% | Percentage of the fund’s portfolio invested in the stock 2.86% | Change in the portfolio weight of the stock over the last 3 months -0.65% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 15/37 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 2.0300% | Percentage of the fund’s portfolio invested in the stock 2.71% | Change in the portfolio weight of the stock over the last 3 months -0.16% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 16/36 (+1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.9253% | Percentage of the fund’s portfolio invested in the stock 3.39% | Change in the portfolio weight of the stock over the last 3 months -0.75% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 13/37 (-8) |
Compare 3-month MF holding change on Screener
smallcases containing ONESOURCE stock
smallcases containing ONESOURCE stock
Looks like this stock is not in any smallcase yet.
ONESOURCE Events
ONESOURCE Events
ONESOURCE Dividend Trend
ONESOURCE has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
ONESOURCE Dividend Trend
ONESOURCE has not given any dividends in last 5 years
ONESOURCE Dividends
ONESOURCE Dividends
ONESOURCE Stock News & Opinions
ONESOURCE Stock News & Opinions
OneSource Specialty Pharma Ltd share price rallied 13.96% to Rs 1591.25 after the company's net profit soared by 129.92% to Rs 57.48 crore, while revenue from operations gained 14.97% to Rs 516.24 crore in Q3FY26 over Q2FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.44 lakh crore, rising 4.06%. It has marginally improved by 3.17% over last one week and edged lower by 0.26% in last one month while the market capitalization of OneSource Specialty Pharma Ltd has sharply increased by 17.77% and 5.50% in the same period respectively. Profit before tax (PBT) of OneSource Specialty Pharma Ltd stood at Rs 52.87 crore in Q3 FY26, jumping 821.08% year-on-year, and rallying 160.57% quarter-on-quarter. EBITDA came in at Rs 162 crore, surging by 56.91% YoY and expanding by 35.79% sequentially. Total expenses saw a slight increase of 7.69% to Rs 428.0 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 152.25 crore, growing marginally by 7.83% YoY, while employee benefits expense was at Rs 77.58 crore, witnessing a strong rise of 12.96% YoY. For the TTM ended FY26, revenue from operations softened by 1.61% to Rs 1421.59 crore, while net profit surged by 327.08% to Rs 73.8 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 45325% to Rs 289.2 crore, and PBT soared 37.11% to Rs 91.96 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 8.52 crore in FY26, as against Rs 67.85 crore in FY25. OneSource Specialty Pharma Ltd crashed 11.98% in last one year, outperforming the benchmark BSE Sensex which has reduced by 13.19% during the same period.
Sona BLW Precision Forgings Ltd, Acutaas Chemicals Ltd, Dalmia Bharat Ltd, Ola Electric Mobility Ltd are among the other stocks to see a surge in volumes on NSE today, 27 October 2026.OneSource Specialty Pharma Ltd witnessed volume of 63.3 lakh shares by 14:24 IST on NSE, a 37.65 times surge over two-week average daily volume of 1.68 lakh shares. The stock increased 13.79% to Rs.1,590.00. Volumes stood at 2.28 lakh shares in the last session.Sona BLW Precision Forgings Ltd registered volume of 173.84 lakh shares by 14:24 IST on NSE, a 8.45 fold spurt over two-week average daily volume of 20.57 lakh shares. The stock rose 8.07% to Rs.845.00. Volumes stood at 30.96 lakh shares in the last session.Acutaas Chemicals Ltd recorded volume of 39.9 lakh shares by 14:24 IST on NSE, a 8.39 times surge over two-week average daily volume of 4.76 lakh shares. The stock gained 15.86% to Rs.3,880.00. Volumes stood at 12.45 lakh shares in the last session.Dalmia Bharat Ltd saw volume of 5.83 lakh shares by 14:24 IST on NSE, a 7.64 fold spurt over two-week average daily volume of 76305 shares. The stock dropped 7.31% to Rs.1,506.90. Volumes stood at 54656 shares in the last session.Ola Electric Mobility Ltd registered volume of 2419.11 lakh shares by 14:24 IST on NSE, a 6.78 fold spurt over two-week average daily volume of 356.63 lakh shares. The stock rose 11.89% to Rs.33.50. Volumes stood at 436.09 lakh shares in the last session.
OneSource Specialty Pharma Ltd share price inched up 4.77% to Rs 1396.3 after the company's net profit jumped 129.92% to Rs 57.48 crore, while revenue from operations increased 14.97% to Rs 516.24 crore in Q3FY26 over Q2FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.54 lakh crore, rising 3.42%. It has marginally improved by 0.07% over last one week and softened by 3.01% in last one month while the market capitalization of OneSource Specialty Pharma Ltd has improved by 1.22% and 20.12% in the same period respectively. Profit before tax (PBT) of OneSource Specialty Pharma Ltd stood at Rs 52.87 crore in Q3 FY26, expanding by 821.08% year-on-year, and rallying 160.57% quarter-on-quarter. EBITDA came in at Rs 162 crore, jumping 56.91% YoY and surging by 35.79% sequentially. Total expenses grew marginally by 7.69% to Rs 428.0 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 152.25 crore, posting a minor increase of 7.83% YoY, while employee benefits expense was at Rs 77.58 crore, witnessing a strong rise of 12.96% YoY. For the TTM ended FY26, revenue from operations declined slightly by 1.61% to Rs 1421.59 crore, while net profit surged by 327.08% to Rs 73.8 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 45325% to Rs 289.2 crore, and PBT soared 37.11% to Rs 91.96 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 8.52 crore in FY26, as against Rs 67.85 crore in FY25. OneSource Specialty Pharma Ltd plunged by 22.77% in last one year, underperforming the benchmark BSE Sensex which has slipped by 13.18% during the same period.
India Glycols Ltd, Ola Electric Mobility Ltd, Zaggle Prepaid Ocean Services Ltd and Sona BLW Precision Forgings Ltd are among the other gainers in the BSE's 'A' group today, 27 October 2026.OneSource Specialty Pharma Ltd spiked 12.08% to Rs 1565 at 11:47 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 75450 shares were traded on the counter so far as against the average daily volumes of 31599 shares in the past one month. India Glycols Ltd soared 11.93% to Rs 320.3. The stock was the second biggest gainer in 'A' group. On the BSE, 46350 shares were traded on the counter so far as against the average daily volumes of 1.6 lakh shares in the past one month. Ola Electric Mobility Ltd surged 10.89% to Rs 33.19. The stock was the third biggest gainer in 'A' group. On the BSE, 88.99 lakh shares were traded on the counter so far as against the average daily volumes of 41.7 lakh shares in the past one month. Zaggle Prepaid Ocean Services Ltd advanced 10.74% to Rs 167.55. The stock was the fourth biggest gainer in 'A' group. On the BSE, 2.73 lakh shares were traded on the counter so far as against the average daily volumes of 54853 shares in the past one month. Sona BLW Precision Forgings Ltd gained 8.92% to Rs 853.85. The stock was the fifth biggest gainer in 'A' group. On the BSE, 6.57 lakh shares were traded on the counter so far as against the average daily volumes of 3.16 lakh shares in the past one month.
OneSource Specialty Pharma Limited announced that the board of directors approved a change in designation for Dr. Claudio Albrecht, shifting his role from Independent Director to Non-Executive Non-Independent Director, effective October 27, 2026, subject to shareholder approval. Dr. Albrecht is Co-Founder and Managing Partner of Albrecht, Prock & Partners AG and previously held leadership positions at Ratiopharm Group, Actavis Group, and STADA AG.
OneSource Specialty Pharma Limited announced the allotment of 360 equity shares under its OneSource ESOP 2021 plan to eligible employees, according to a regulatory filing on October 27, 2026. The allotment increased the company's paid-up share capital from Rs 11,46,73,791 constituting 11,46,73,791 equity shares of Rs 1 each to Rs 11,46,74,151 constituting 11,46,74,151 equity shares of Rs 1 each. The exercise price per share was Rs 278, with a premium of Rs 277.
OneSource Specialty Pharma Limited will hold a board meeting on Tuesday, October 27, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter ended September 30, 2026, according to a regulatory filing with the BSE Limited and National Stock Exchange of India Ltd. The trading window for designated persons of the company was closed from October 1, 2026, and will reopen 48 hours after the financial results are disseminated.
OneSource Specialty Pharma Limited announced the allotment of 900 equity shares of Indian Rupees 1 each under its OneSource ESOP 2021 plan to an eligible employee, according to a circular resolution passed by the company’s Management Committee on September 25, 2026. The allotment increased the company's paid-up share capital from Indian Rupees 11,46,72,891 to Indian Rupees 11,46,73,791, comprising 11,46,73,791 equity shares.
OneSource Specialty Pharma Limited informed the BSE Limited and National Stock Exchange of India Limited that the trading window for dealing in shares of the company will be closed from Thursday, October 01, 2026, until 48 hours after the declaration of financial results for the quarter ended September 30, 2026.
OneSource Specialty Pharma Limited announced that shareholders appointed M/s B S R & Co LLP, Chartered Accountants (Firm’s Registration No.:101248W/W-100022), as its statutory auditors for a period of 5 consecutive years, effective from the conclusion of the 19th Annual General meeting until the conclusion of the 24th Annual General Meeting, during a meeting held on Wednesday, September 23, 2026.
Over the last 5 years, revenue has grown at a yearly rate of 129.84%, vs industry avg of 18.48%
Over the last 5 years, market share increased from 0.19% to 5.18%